Skip to main content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

MyPART - My Pediatric and Adult Rare Tumor Network
 

Selumetinib shrinks pediatric tumors, results of an early-phase clinical trial

Dr. Brigitte Widemann, leader of MyPART, describes her recent success developing treatment for a rare tumor, plexiform neurofibroma, and how natural history studies at NIH lay the foundation for finding new treatments for rare tumors.

Selumetinib shrinks pediatric tumors, results of an early-phase clinical trial